These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33674997)

  • 21. Commentary on: Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Czuczwar SJ
    Epilepsia; 2020 Oct; 61(10):2063-2064. PubMed ID: 33460074
    [No Abstract]   [Full Text] [Related]  

  • 22. [Three children with Lennox-Gastaut syndrome presenting long-term good seizure outcome under rufinamide treatment].
    Tsukamoto K; Takahashi Y; Takayama R
    No To Hattatsu; 2017 Jan; 49(1):54-6. PubMed ID: 30011161
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol for drop seizures in Lennox-Gastaut syndrome.
    Varadkar S
    Lancet; 2018 Mar; 391(10125):1006-1007. PubMed ID: 29395274
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
    Gunning B; Mazurkiewicz-Bełdzińska M; Chin RFM; Bhathal H; Nortvedt C; Dunayevich E; Checketts D
    Acta Neurol Scand; 2021 Feb; 143(2):154-163. PubMed ID: 32969022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?
    Yang YT; Szaflarski JP
    JAMA Neurol; 2019 Feb; 76(2):135-136. PubMed ID: 30452525
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid.
    McNamara NA; Dang LT; Sturza J; Ziobro JM; Fedak Romanowski EM; Smith GC; Joshi SM; Leber SM; Carlson M; Robertson P; Shellhaas RA
    Epilepsia; 2020 Aug; 61(8):e85-e89. PubMed ID: 32614070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol in the Lennox-Gastaut Syndrome.
    Devinsky O; Patel AD; VanLandingham KE
    N Engl J Med; 2018 Aug; 379(8):795. PubMed ID: 30134132
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabidiol in the Lennox-Gastaut Syndrome.
    Feng L; Hoyland L; Poulton A
    N Engl J Med; 2018 Aug; 379(8):794. PubMed ID: 30136545
    [No Abstract]   [Full Text] [Related]  

  • 30. Cannabidiol in the Lennox-Gastaut Syndrome.
    Tampaki EC; Tampakis A; Pantos K
    N Engl J Med; 2018 Aug; 379(8):794. PubMed ID: 30136546
    [No Abstract]   [Full Text] [Related]  

  • 31. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the modified Atkins diet in Lennox Gastaut syndrome.
    Sharma S; Jain P; Gulati S; Sankhyan N; Agarwala A
    J Child Neurol; 2015 Apr; 30(5):576-9. PubMed ID: 24659735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of Cannabidiol to Current Antiepileptic Therapy Reduces Drop Seizures in Children and Adults With Treatment-Resistant Lennox-Gastaut Syndrome.
    Ostrovsky DA; Ehrlich A
    Explore (NY); 2018; 14(4):311-313. PubMed ID: 29887290
    [No Abstract]   [Full Text] [Related]  

  • 34. The proposed mechanisms of action of CBD in epilepsy.
    Gray RA; Whalley BJ
    Epileptic Disord; 2020 Jan; 22(S1):10-15. PubMed ID: 32053110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
    Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
    Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
    Cross JH; Cock H
    Neuropharmacology; 2020 Jun; 170():107861. PubMed ID: 31770546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 39. Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
    Thiele E; Marsh E; Mazurkiewicz-Beldzinska M; Halford JJ; Gunning B; Devinsky O; Checketts D; Roberts C
    Epilepsia; 2019 Mar; 60(3):419-428. PubMed ID: 30740695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.